Stem Cell Research and Application Unit, Department of Biochemistry and Medical Biotechnology, Calcutta School of Tropical Medicine, Calcutta-700073, India.
Curr Stem Cell Res Ther. 2010 Dec;5(4):379-86. doi: 10.2174/157488810793351677.
Leukemia is a heterogeneous disorder of bone marrow (BM) failure syndrome where normal hematopoiesis gets altered due to transformation of either the normal hematopoietic cell or the hematopoietic microenvironment or both. Scientists have tried for decades to understand leukemia development in the context of therapeutic strategies. The existence of "leukemic stem cells" and their possible role in leukemogenesis have only recently been identified and it has changed the perspective with regard to new approaches for treating the disease. However the relationship between leukemic stem cells (LSCs) and leukemogenesis requires further investigation. In this present study, we have experimentally induced leukemia in mice by means of N-N' Ethylnitrosourea (ENU) to investigate the alterations in normal bone marrow cellular phenotype and associated changes in the stromal hematopoietic microenvironment under the event of leukemic disease progression. We have identified a significant decrease in the normal HSC phenotype in terms of Sca1 and c-kit receptor expression and subsequent sharp increase in certain leukemic cell specific receptor expression like CD123, CXCR4 and CD44 in the leukemic bone marrow. The decreased HSC receptor (Sca1 and c-kit) expression profile with concurrent increase in the expression of leukemic cell specific receptors (CD123, CXCR4, CD44) by the bone marrow cells of leukemic mice may account for the possible transformation of the normal hematopoietic cells that is necessary for the disease initiation and progression. Some of these receptors like CXCR4 and CD44 are also known to play an important role in maintaining leukemic cells and their complex crosstalk with the surrounding stromal microenvironment. Thus up-regulation in CXCR4 and CD44 receptor expression essentially pointed towards the stroma dependent surveillance of the leukemic bone marrow cells in leukemia. Leukemic bone marrow cells documented a rapid generation of stromal feeder layer in culture. The rapid stroma generation further supported the fact that leukemic stromal microenvironment gets altered in possible ways to support leukemic cell generation and fueling leukemogenesis. The study presented here, has tried to hint at exploring new therapeutic strategies by not only identifying the expression profile of cell surface receptors unique to cells involved in leukemic progression but also targeting the specific components of the stromal microenvironment that would facilitate therapeutic management of the disease.
白血病是一种骨髓(BM)衰竭综合征的异质性疾病,正常造血由于正常造血细胞或造血微环境或两者的转化而改变。几十年来,科学家们一直在努力从治疗策略的角度理解白血病的发展。“白血病干细胞”的存在及其在白血病发生中的可能作用最近才被确定,这改变了治疗这种疾病的新方法的观点。然而,白血病干细胞(LSCs)与白血病发生之间的关系需要进一步研究。在本研究中,我们通过 N-N'亚乙基硝脲(ENU)在小鼠中诱导白血病,以研究白血病疾病进展过程中正常骨髓细胞表型的改变以及基质造血微环境的相关变化。我们发现,白血病骨髓中某些白血病细胞特异性受体的表达明显增加,如 CD123、CXCR4 和 CD44,而正常 HSC 表型的 Sca1 和 c-kit 受体表达显著降低。白血病小鼠骨髓细胞中 HSC 受体(Sca1 和 c-kit)表达谱的降低与白血病细胞特异性受体(CD123、CXCR4、CD44)的表达同时增加,可能是正常造血细胞转化所必需的,这种转化是疾病起始和进展所必需的。这些受体中的一些,如 CXCR4 和 CD44,也已知在维持白血病细胞及其与周围基质微环境的复杂相互作用中发挥重要作用。因此,CXCR4 和 CD44 受体表达的上调本质上表明了白血病骨髓细胞在白血病中的基质依赖性监测。白血病骨髓细胞在培养中迅速产生基质饲养层。快速产生基质进一步支持了这样一个事实,即白血病基质微环境以可能的方式发生改变,以支持白血病细胞的产生和促进白血病发生。本研究试图通过不仅鉴定参与白血病进展的细胞表面受体的表达谱,而且还鉴定基质微环境的特定成分,来暗示探索新的治疗策略,这些成分将有助于疾病的治疗管理。